HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both.

Abstract
Both carbon monoxide (CO) and biliverdin, products of heme degradation by heme oxygenase, have been shown to attenuate ischemia/reperfusion (I/R) injury. We hypothesized in this study that dual-treatment with CO and biliverdin would induce enhanced protective effects against cold I/R injury. Heterotopic heart and orthotopic kidney transplantation were performed in syngeneic Lewis rats after 24-h cold preservation in UW solution. While monotherapy with CO (20 ppm) or biliverdin (50 mg/kg, ip) did not alter the survival of heart grafts, dual-treatment increased survival to 80% from 0% in untreated recipients, with a significant decrease of myocardial injury and improved cardiac function. Similarly, dual-treatment significantly improved glomerular filtration rates of renal grafts and prolonged recipient survival compared to untreated controls. I/R injury-induced up-regulation of pro-inflammatory mediators (e.g. TNF-alpha, iNOS) and extravasation of inflammatory infiltrates were significantly less with dual-treatment than untreated controls. In addition, dual-treatment was effective in decreasing lipid peroxidation and improving graft blood flow through the distinctive action of biliverdin and CO, respectively. The study shows that the addition of byproducts of heme degradation with different mechanisms of action provides enhanced protection against transplant-associated cold I/R injury of heart and kidney grafts.
AuthorsAtsunori Nakao, Joao Seda Neto, Shinichi Kanno, Donna B Stolz, Kei Kimizuka, Fang Liu, Fritz H Bach, Timothy R Billiar, Augustine Mk Choi, Leo E Otterbein, Noriko Murase
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 5 Issue 2 Pg. 282-91 (Feb 2005) ISSN: 1600-6135 [Print] United States
PMID15643987 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carbon Monoxide
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • Biliverdine
  • Oxygen
Topics
  • Animals
  • Biliverdine (therapeutic use)
  • Carbon Monoxide (therapeutic use)
  • Cell Movement (physiology)
  • Heart Transplantation
  • Heme Oxygenase (Decyclizing) (biosynthesis, genetics)
  • Heme Oxygenase-1
  • Kidney Transplantation
  • Macrophages (physiology)
  • Male
  • Oxygen (metabolism)
  • Rats
  • Rats, Inbred Lew
  • Reperfusion Injury (drug therapy, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: